DIA Biosimilars 2013

Articles Published in 2011

Cedars-Sinai Medical Center selects Voalté's iPhone platform

Tuesday, November 8, 2011 03:25 PM
Voalté, a clinical communication technology and software for healthcare institutions, and Cedars-Sinai Medical Center have launched Voalté’s point-of-care communication solution, consolidating voice, alarm and text on the versatile iPhone platform.

More... »

Cenduit: Now with Patient Reminders

Battelle, Molecular Imaging collaborate in R&D

Tuesday, November 8, 2011 03:07 PM
Battelle, an independent research and development organization, has enhanced its discovery and development services through a collaboration with Molecular Imaging, a provider of small-scale nonclinical in vivo multi-modality imaging services.

More... »

CRF Health – eCOA Forum

BioTrak Research launches Patient Recruiters International

Tuesday, November 8, 2011 11:34 AM

BioTrak Research, a contract research organization, has launched Patient Recruiters International, a full-service patient recruitment organization.

More... »

Sentinel Captial acquires WellSpring Pharmaceutical

Tuesday, November 8, 2011 10:31 AM

Sentinel Capital Partners has acquired WellSpring Pharmaceutical. Sentinel completed the transaction alongside Ancor Capital Partners.

More... »

Dendreon names Fenton to board of directors

Tuesday, November 8, 2011 10:12 AM

Dendreon has named Dennis M. Fenton to the board of directors, effective November 8, 2011.

More... »

Axio Research expands services into China

Monday, November 7, 2011 02:07 PM

Axio Research, a North American independent data coordinating center, has expanded its services into Shanghai, China.

More... »

NPS Pharmaceuticals' phase III REPLACE study shows positive results

Monday, November 7, 2011 01:06 PM

NPS Pharmaceuticals has reported positive top-line results from REPLACE, a phase III registration study of NPSP558, the company's bioengineered replica of human parathyroid hormone (rhPTH 1-84), in adult hypoparathyroidism patients. NPS has received orphan drug status for NPSP558 for the treatment of hypoparathyroidism, a rare endocrine disorder in which the body produces insufficient levels of parathyroid hormone, the principal regulator of calcium and phosphorus, and for which there is no FDA-approved replacement therapy. The symptoms of hypoparathyroidism are typically managed with large doses of oral calcium supplementation and active vitamin D therapy to reduce the severity of symptoms. The prolonged use of oral calcium supplementation and active vitamin D therapy may result in serious long-term health complications.

More... »

CoreRx launches FLEXITAB

Monday, November 7, 2011 12:27 PM

CoreRx has further enhanced its offering by adding the Bosch Manesty FLEXITAB, a fully automated, single station tablet press with a multi-layer tablet function, giving it the unique capacity to produce multi-layer (up to three-layer) tablets using a minimal amount of material. Its variable punch displacement and dwell time can be set to simulate compression on any rotary press using compression forces up to100kN.

More... »

Report: Clinical trials approved in Russia on course in third quarter

Monday, November 7, 2011 11:26 AM

The number of new studies approved in Russia during the third quarter of 2011 reached last year’s level, with the Ministry of Health and Social Development of the Russian Federation (MoH) approving 132 new clinical trials of all types, including local and bioequivalence studies, according to Synergy Research Group (SynRG), a Russia-based CRO. That’s only two trials below the number approved in the year-ago quarter.

More... »

Advanced Clinical names director of clinical operations

Monday, November 7, 2011 11:19 AM
Advanced Clinical has named Michaelene Lewand director of clinical operations to lead its expansion of service offerings.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.